HeartBeam, Inc.

# HeartBeam, Inc.

Incorporated in Delaware and listed on Nasdaq under the ticker BEATW, HeartBeam operates in the surgical and medical instruments sector. The company develops diagnostic and monitoring devices focused on cardiac applications, with particular emphasis on electrocardiogram (ECG) and related cardiovascular assessment technologies. Its product portfolio is designed for use in clinical settings, including hospitals and cardiac care facilities.

The company's primary revenue stream derives from its cardiac diagnostic device offerings, which include hardware and associated software platforms. HeartBeam's technology targets the detection and monitoring of cardiac conditions, positioning its products within the broader market for non-invasive cardiac assessment tools. The company serves healthcare providers and institutions requiring electrocardiographic monitoring and diagnostic capabilities.

HeartBeam operates as a smaller-scale medical device manufacturer with a limited employee base relative to larger instrumentation companies. The company maintains operations primarily in the United States, though its distribution and market reach extend to select international territories. As a specialized medical device developer, HeartBeam's revenue scale reflects the niche nature of its cardiac diagnostic focus and the regulatory requirements inherent to the medical device industry.